Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
65.06
-1.45 (-2.18%)
At close: Sep 3, 2025, 4:00 PM
64.42
-0.64 (-0.99%)
After-hours: Sep 3, 2025, 7:30 PM EDT
Guardant Health Revenue
Guardant Health had revenue of $232.09M in the quarter ending June 30, 2025, with 30.95% growth. This brings the company's revenue in the last twelve months to $828.85M, up 28.74% year-over-year. In the year 2024, Guardant Health had annual revenue of $739.02M with 31.04% growth.
Revenue (ttm)
$828.85M
Revenue Growth
+28.74%
P/S Ratio
9.71
Revenue / Employee
$410,118
Employees
2,021
Market Cap
8.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 739.02M | 175.07M | 31.04% |
Dec 31, 2023 | 563.95M | 114.41M | 25.45% |
Dec 31, 2022 | 449.54M | 75.89M | 20.31% |
Dec 31, 2021 | 373.65M | 86.92M | 30.32% |
Dec 31, 2020 | 286.73M | 72.36M | 33.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
GH News
- 6 days ago - Guardant Health to Host Investor Day on September 24, 2025 - Business Wire
- 8 days ago - Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 19 days ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 4 weeks ago - American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
- 4 weeks ago - Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 4 weeks ago - Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Benzinga
- 4 weeks ago - Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript - Seeking Alpha